LABDASH
DEAD

Serial Number

90773927

Owner

VISBY MEDICAL, INC.

Attorney

Rebecca L. Wilson

Filing Date

Jun 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LABDASH Trademark

Serial Number: 90773927

LABDASH is a trademark filed by VISBY MEDICAL, INC. on June 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

VISBY MEDICAL, INC. (20 trademarks)

SAN JOSE, CA 95134

Entity Type: 03

Trademark Details

Filing Date

June 15, 2021

Registration Date

Not Registered

Published for Opposition

May 3, 2022

Goods & Services

Downloadable and recorded computer application software for mobile phones, namely, software for scheduling omic testing; Downloadable and recorded computer application software for mobile phones, namely, software for receiving omic testing results

Specimen collection kits comprised primarily of swabs for medical purposes and also including collection tools for obtaining samples, containers for handling or transport of samples, personal protective equipment, and disposal containers; Specimen collection kits comprised primarily of swabs for medical purposes and also including collection tubes, gloves, specimen containers, tube holders, power adapters, instructions, and screening device for use in diagnosing various medical conditions

Electronic data collection and data submission services for business purposes in the field of healthcare; electronic data collection and data submission services for business purposes in the fields of infectious and non-infectious diseases and conditions; online scheduling and ordering services in the field of omics testing

Mobile medical testing services relating to the diagnosis and treatment of disease; Mobile medical diagnostic testing, monitoring, and reporting services; Mobile medical diagnostic testing, monitoring and reporting services in the field of infectious diseases, cancers, and neurological diseases and conditions; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical information services, namely, reporting of consumer-authorized clinical test results directly to the patient; Providing medical information to patients and medical professionals in the form of reports in the field of infectious diseases, cancers, and neurological diseases and conditions; Medical testing services relating to the diagnosis and treatment of infectious diseases, cancers, and neurological diseases and conditions; Medical consultation services in the field of health care and the detection of infectious and non-infectious diseases and conditions; Health screening services in the field of infectious diseases, cancers, and neurological diseases and conditions

Medical instruments for use in taking samples for diagnosing, screening, monitoring or researching various medical conditions

Data automation and collection service using proprietary software to evaluate, analyze, and collect health care data obtained from a portable medical testing device; electronic data storage in the field of healthcare; data automation and collection service using proprietary software to evaluate, analyze, and collect omics data regarding infectious and non-infectious diseases and conditions; electronic data storage in the field of infectious and non-infectious diseases and conditions; consultation services regarding the design and development of medical omics testing devices; Mobile medical clinical laboratory services

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 31, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 31, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 30, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 28, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 28, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 28, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 27, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 27, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 27, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2021 NWOS
NEW APPLICATION ENTERED
Jun 18, 2021 NWAP